期刊文献+

大规模随机临床试验与心血管病临床治疗进展

Progress in Large Scale Random Clinical Experiment and Clinical Therapy of Cardiovascular Disease
下载PDF
导出
作者 王文
出处 《中国分子心脏病学杂志》 CAS 2005年第2期449-451,共3页 Molecular Cardiology of China
  • 相关文献

参考文献12

  • 1王文,刘力生,陶寿淇,龚兰生,吴宁.我国大样本心血管药物临床试验的回顾与展望[J].中华心血管病杂志,2000,28(5):335-338. 被引量:18
  • 2王文,马丽媛,张宇清,邹效漫.吲哒帕胺治疗高血压脑卒中的证据[J].中华高血压杂志,2003,13(z1):22-24. 被引量:3
  • 3王文,马丽媛,邓卿,邹效漫.降压治疗预防糖尿病患者血管事件的证据-11项大样本随机对照临床试验回顾分析[J].高血压杂志,2004,12(3):188-190. 被引量:3
  • 4王文,邓卿,何华,马丽媛.降压治疗对脑卒中二级预防的临床证据[J].中国循证医学杂志,2004,4(5):355-358. 被引量:15
  • 5[6]Schunemann HJ, Cook D, Grimshaw J, et al. Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh AC-CP Conference on Antithrombotic and Thrombolytic Therapy. Chest,2004,126:688 S-696S.
  • 6[7]PROGRESS Collaborative Group. Randomised trial of a perindoprilbased blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet, 2001,358:1033-1041.
  • 7[8]McAlister FA, Levine M, Zarnke KB, et al. The 2000 Canadian recommendations for the management of hypertension: part one-therapy. Can J Cardiol,2001,17 :543-559.
  • 8[9]The CREATE Trial Group Invastigators. Effects of reviparin, a lowmolecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA, 2005, 293:437-489.
  • 9[10]The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomised to angiotesin-coverting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA,2002, 288:2981-2997.
  • 10[11]Prisant LM. Diabetes mellitus and hypertension: a mandate for intense treatment according to new guidelines. Am J Ther, 2003,10:363 -369 .

二级参考文献19

  • 1吴宁.开展对心律失常的临床试验和机制研究[J].中华心血管病杂志,1996,24(6):403-403. 被引量:6
  • 2PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure-lowering regimen among 6 105 individuals with previous stroke or transient ischemic attack[J]. Lancet, 2001; 358(9 287):1 033-1 041
  • 3Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.Effects of an angiotensin-eonverting-enzyme inhibitor, ramipril,on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators[ J]. N Engl J Med, 2000
  • 4Wang W, Lin LS. Relationship between blood pressure level and stroke recurrence[J]. Chin J Hypertens, 2003; 11:106 -108
  • 5Dutch TIA Trial Group. Trial of secondary prevention with atenolol after transient ischemic attack or nondisabling ischemic stroke[J]. Stroke, 1993; 24(4) :543 -548
  • 6Rodgers A, Neal B, MacMahon S. The effects of blood pressure lowering in cerebrovascular disease [ J ]. Neurol Rev Int,1997; 2:12-15
  • 7Hypertension Stroke Cooperative Study Group. Effect of antihypertensive treatment on stroke recurrence[J]. J Am Med Assoc, 1974; 229:409 - 418
  • 8King H,Anber R,Herman W,et al.1995-2025,Prevalence,numerical estimates,and projections[J].Diabetes Care,1998,21:1414-1431.
  • 9Kuller L,Velentgas P,Barzilay J,et al.Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and allcause mortaliy[J ].Arterioscler Thromb Vasc Biol,2000,20: 823-829.
  • 10Estacio RO,Jeffers BW,Hiatt WR,et al.The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with noninsulin-dependent diabetes and hypertension [J ].N Engl J Med,1998,338: 645-652.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部